European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS827 Category:

The NGS services market in Europe is expected to reach USD 2.5 billion by 2024, rising at CAGR by 19.5% from 2019 to 2024. Factors such as growing preference for NGS over other platforms; rapid and cost-effective sequencing; increasing prevalence of inherited diseases; genomics in drug discovery; increasing prevalence of cancer and other malignant diseases; and collaborations between businesses, R&D centers and universities are expected to drive market growth.

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 1

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 2

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 3

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 4

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 5

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 6

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 7

European NGS Services Market by Technology (SBL, SBS, Pyrosequencing, SMRT), Application (CHIP-Seq, Exome Sequencing), Disease (Oncology (Lung, Prostate, & Breast Cancer), Rare Diseases), End-User Industry (Hospital, Pharmaceutical Companies) - 2019 to 2024 8

1 Global European NGS Services Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global European NGS Services Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global European NGS Services Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global European NGS Services Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global European NGS Services Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global European NGS Services Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global European NGS Services Market – By Technology (Market Size – & million/billion)
8.1 Sequencing by Synthesis (SBS)
8.2 Ion Semiconductor
8.3 Sequencing by Ligation (SBL)
8.4 Pyro-sequencing
8.5 SMRT

9 Global European NGS Services Market – By Application
9.1 Research Applications
9.2 Clinical Applications

10 Global European NGS Services Market – By Disease Type
10.1 Oncology
10.2 Lung Cancer
10.3 Breast Cancer
10.4 Prostate Cancer
10.5 Colorectal Cancer
10.6 Others

11 Global European NGS Services Market – By End-User
11.1 Research Centers and Academic & Government Institutes
11.2 Hospitals and Clinics
11.3 Pharmaceutical and Biotechnology Companies
11.4 Other

12 Global European NGS Services Market – By Geography (Market Size – & million/billion)
12.1.1 U.K.
12.1.2 Germany
12.1.3 France
12.1.4 Italy
12.1.5 Spain
12.1.6 Netherlands
12.1.7 Rest of the Europe

13 Global European NGS Services Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global European NGS Services Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Beijing Genomics Institute (BGI)
14.3 Macrogen Inc.
14.4 Microsynth AG
14.5 Seqomics
14.6 DNA Vision SA
14.7 Genomnia Srl
14.8 Illumina Inc.
14.9 Cegat (Centre for Genomics and Transcriptomics) GmbH
14.10 Eurofins Genomics Inc.
14.11 Febit / Comprehensive Biomarker Center GmbH (CBC)
14.12 Company 11 & more

15 Global European NGS Services Market – Appendix
15.1 Sources
15.2 Abbreviations